Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

Magnetic compression simplifies revisional sleeve gastrectomy

The preliminary findings from a multi-centre study assessing magnetic gastroileostomy bipartition (MagGI procedure) as a revisional option for suboptimal sleeve gastrectomy (SG), suggest that SG-revisional MagGI was technically feasible and achieved promising excess weight loss of 66.0%. Self-aligning GT Metabolic MagDI System magnets fused together The study was conducted in adults (body mass index [BMI, kg/m2] ≥30.0–≤50.0). The 90-day primary feasibility endpoint was magnet

Magnetic compression simplifies revisional sleeve gastrectomy

IFSO ‘cautiously’ supports the selective use of ring augmentation in both primary and revisional MBS

Rise in GLP-1 treatment for bariatric surgery-eligible patients

Research

Researchers uncover mechanism explaining how obesity increases cancer risk

Scientists at City of Hope and TGen (part of City of Hope) have explained a major mechanism for why gaining excess weight increases the risk of cancer across multiple organs. The findings emphasise the importance of maintaining a healthy weight from early childhood and propose a potentially more accurate way than body mass index (BMI) to predict the increase in cancer risk associated with obesity. "People have long been told that obesity increases cancer risk, but they are ra

Magnetic compression simplifies revisional sleeve gastrectomy

GLP-1s may affect some complications after panniculectomy

For patients undergoing body contouring surgery to remove excess abdominal skin after significant weight loss, use of GLP-1 weight-loss medications may have mixed effects on complication risks, according to a study by researchers from West Virginia University School of Medicine, Morgantown, WV. Share of all patients who take a GLP-1 RA by state. Credit: Plastic & Reconstructive Surgery (2025). DOI: 10.1097/prs.0000000000012405 "As GLP-1 receptor agonist (GLP1ra) medications b

Broward Health surgeon achieves milestone with 2,555 robotic-assisted procedures

Dr Alexander Parr, a board-certified general and bariatric surgeon with the Broward Health Physician Group, has reached a milestone achievement, performing his 2,555th robotic-assisted procedure using the Da Vinci Surgical System at Broward Health Imperial Point, marking a significant landmark in his career and underscoring Broward Health’s commitment to advanced surgical technology. Alexander Parr “Reaching 2,555 robotic-assisted procedures is an exciting milestone, but more

Amylyx completes LUCIDITY Clinical Trial enrolment assessing avexitide for post-bariatric hypoglycemia

The last participant has been randomised and dosed in Amylyx Pharmaceuticals’ pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist with an FDA Breakthrough Therapy Designation in post-bariatric hypoglycemia (PBH). LUCIDITY is a 16-week, multicentre, randomised, double-blind, placebo-controlled trial evaluating the efficacy and safety of avexitide in adults with PBH following Roux-en-Y gast

RYGB and SADI-S are effective and safe revisional options after SG

Both Roux-en-Y gastric bypass (RYGB) and single-anastomosis duodeno-ileal bypass (SADI-S) are effective and safe revisional options after sleeve gastrectomy (SG), according to researchers from Hamad Medical Corporation, Doha, Qatar. They noted that SADI-S offers superior long-term weight-loss and metabolic outcomes, whereas RYGB remains preferable for patients with significant or persistent GERD. “Tailoring revisional procedure selection to patient characteristics and ensurin

Understanding of the therapeutic role of MBS for T2DM remained limited among the general public

Researchers from Saudi Arabia have reported that although general awareness of obesity’s metabolic impact is high, understanding of the therapeutic role of metabolic bariatric surgery for T2DM remained limited. Despite that fact that injectable therapies were more frequently preferred than surgical options, their study did not find definitive conclusions regarding the underlying drivers of these preferences. “These findings highlight the need for structured public education i

MBS in adolescents ‘reprograms’ kidney biology promoting recovery

Researchers from Northwestern Medicine at Northwestern University, Chicago, Ill, have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney disease following bariatric surgery in adolescents with type 2 diabetes and obesity. These mechanisms may serve as potential targets for non-surgical treatments for diabetic kidney disease, according to a multi-institutional study co-authored by Dr Thomas Inge, the Lydia J Fredrickson Board Designated Prof

Higher occurrence of marginal ulcers RYGB compared with OAGB

Marginal ulcers (MU) occurred at a relatively high rate after Roux-en-Y gastric bypass (RYGB) compared with one-anastomosis gastric bypass (OAGB), according to a study by researchers from the Kasr Alainy Medical School, Cairo University, Cairo, Egypt. They noted that type 2 diabetes mellitus (T2DM) and the RYGB procedure were significant predictors of MU after adjusting for the confounding factors. The authors noted that despite the success of RYGB, MU has been recognised as

GLP-1 may help alleviate symptoms of anxiety and depression

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, according to a large register-based study carried out in collaboration between the University of Eastern Finland, Karolinska Institutet in Stockholm and Griffith University in Australia. Infographic on anxiety and depression in the UK (Credit: Mark Taylor) "An earlier study examining Swedish registers found the use of GLP-

IFSO ‘cautiously’ supports the selective use of ring augmentation in both primary and revisional MBS

In a recent position statement, the International Federation for the Surgery and Other Therapies for Obesity (IFSO) has ‘cautiously’ supported the selective use of ring augmentation (ra) in both primary and revisional metabolic bariatric surgery (MBS), particularly for Roux-en-Y Gastric Bypass (raRYGB). The findings were reported in the paper, ‘Ring-augmented Metabolic Bariatric Surgery Procedures GRADE based International Federation for the Surgery of Obesity and Metabolic

Study identifies how obesity-related liver cancer becomes more aggressive and resistant to treatment

A research team affiliated with National Institute of Standards and Technology has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to conventional treatments. The study reveals that a specific signalling pathway involving endotrophin - a protein secreted during liver fibrosis - and the receptor protein CD44 promotes tumour malignancy and drug resistance. Led by Professor J

Industry

Olympus launches next-generation VISERA ELITE III surgical imaging platform in US

FDA approves Allurion Gastric Balloon System

Europe approves 7.2 mg injectable Wegovy for adults with obesity

FDA approves Novo Nordisk's oral GLP-1 for weight loss

All caught up?

See all news

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Browse directory

Events

14th Congress of the European Chapter of the International Federation for the Surgery and Other Therapies For Obesity

View details

Headlines

Magnetic compression simplifies revisional sleeve gastrectomy

Magnetic compression simplifies revisional sleeve gastrectomy

Magnetic compression simplifies revisional sleeve gastrectomy

IFSO ‘cautiously’ supports the selective use of ring augmentation in both primary and revisional MBS

Rise in GLP-1 treatment for bariatric surgery-eligible patients

Research

Researchers uncover mechanism explaining how obesity increases cancer risk

Magnetic compression simplifies revisional sleeve gastrectomy

GLP-1s may affect some complications after panniculectomy

Broward Health surgeon achieves milestone with 2,555 robotic-assisted procedures

Amylyx completes LUCIDITY Clinical Trial enrolment assessing avexitide for post-bariatric hypoglycemia

RYGB and SADI-S are effective and safe revisional options after SG

Understanding of the therapeutic role of MBS for T2DM remained limited among the general public

MBS in adolescents ‘reprograms’ kidney biology promoting recovery

Higher occurrence of marginal ulcers RYGB compared with OAGB

GLP-1 may help alleviate symptoms of anxiety and depression

IFSO ‘cautiously’ supports the selective use of ring augmentation in both primary and revisional MBS

Study identifies how obesity-related liver cancer becomes more aggressive and resistant to treatment

Industry

Olympus launches next-generation VISERA ELITE III surgical imaging platform in US

FDA approves Allurion Gastric Balloon System

Europe approves 7.2 mg injectable Wegovy for adults with obesity

FDA approves Novo Nordisk's oral GLP-1 for weight loss

All caught up?

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Events

(See all)

4th Annual International Symposium on Magnetic Gastrointestinal & Colon Surgery

XXIX IFSO World Congress

6th London International Bariatric Surgery Symposium (LIBSS)

4th IFSO MENAC Meeting

BOMSS ASM 2026

2026 IBC University of Oxford World Congress

14th Congress of the European Chapter of the International Federation for the Surgery and Other Therapies For Obesity

Tweets

Back to Top